Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab,lenalidomide
Janssen
['lenalidomide', ' lena', 'cilta-cel', 'mmsm']
cilta-cel possesses potential to be new soc for lenalidomide-refractory myeloma after first relapse #asco23 #asco2023 #mmsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.